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The prevalence of obesity is increasing rapidly globally and has recently reached pandemic proportions. It is a 
multifactorial disorder linked to a number of non-communicable diseases such as type-2 diabetes, 
cardiovascular disease, and cancer. Over-nutrition and a sedentary lifestyle are considered the most significant 
causes of obesity; a healthy lifestyle and behavioural interventions are the most powerful ways to achieve 
successful weight loss, but to maintain this in the long term can prove difficult for many individuals, without 
medical intervention. Various pharmacological anti-obesogenic drugs have been tested and marketed in the 
past and have been moderately successful in the management of obesity, but their adverse effects on human 
health often outweigh the benefits. Natural products from plants, either in the form of crude extracts or purified 
phytochemicals, have been shown to have anti-obesogenic properties and are generally considered as nontoxic 
and cost-effective compared to synthetic alternatives. These plant products combat obesity by targeting the 
various pathways and/or regulatory functions intricately linked to obesity. Their mechanisms of action include 
inhibition of pancreatic lipase activities, an increase in energy expenditure, appetite regulation, lipolytic effects, 
and inhibition of white adipose tissue development. In this review, we discuss the distinct anti-obesogenic 
properties of recently reported plant extracts and specific bioactive compounds, along with their molecular 
mechanisms of action. This review will provide a common platform for understanding the different causes of 
obesity and the possible approaches to using plant products in tackling this worldwide health issue. 
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Nomenclature 
ACC Acetyl-coenzyme A carboxylase 
ACSL1 Long-chain-fatty-acid-CoA ligase 1 
AMPK Adenosine monophosphate activated protein kinase 
ATGL Adipocytes triglycerides lipase 
C/EBP-α CCAAT/Enhancer binding protein-alpha 
C/EBP-β CCAAT/Enhancer binding protein-beta 
Cited 1     Cbp/p300-interacting trans activator 1 
CPT1      Carnitine palmitoyl transferase 1 
DGAT1 Diacylglycerol O-acyltransferase 1 
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FATP4      Fatty acid transport protein 4 
FFAs     Free fatty acids 
GLUT4      Glucose transporter 4 
GSK-3β    Glycogen synthase kinase-3 beta 
HMGR      HMG-CoA reductase 
hMSC     human Mesenchymal stem cells 
HSL     Hormone sensitive lipase 
iWAT  Inguinal white adipose 
tissue LPL     Lipoprotein lipase 
MAGL      Monoacylglycerol lipase 
p-ACC     Phosphorylated acetyl-CoA carboxylase 
pAMPK  phosphorylated Adenosine monophosphate activated protein kinase 
PGC-1α  Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
PLIN     Perilipin 
PPAR-γ     Peroxisome proliferator activated receptor–Gamma 
PRDM-16     PR Domain containing 16 
Sirt 1     Sirtuin 1 
SREBP     Sterol regulatory element binding protein 
sWAT         Subcutaneous white adipose tissue 
Tbx1      T-box transcription factor 1 
TG     Triglycerides 
TMEM 26      Transmembrane protein 26 
UCP1     Uncoupling protein1 
 
1 Introduction 
Obesity can be defined as a body mass index (BMI; weight in kg/square of the body height in metres) of over 30 kg/m2 
(Khalilpourfarshbafi et al., 2018). Obesity is an international issue and a risk factor for other diseases including 
cardiovascular diseases, cancer, type-2 diabetes, asthma, atherosclerosis, and non-alcoholic fatty liver disease (NAFLD) 
(Corrêa and Rogero, 2019; Peters et al., 2018; Unamuno et al., 2018). Obesity and being overweight are the fifth leading 
causes of death globally (Chandrasekaran et al., 2012). According to one estimation, approximately 921 million people 
were obese or overweight throughout the world in 1980 and by 2013 this number had increased to 2.1 billion ( Castillo et 
al., 2019; Ng et al., 2014) – increasing from approximately 20%–30% of the global population. It is now widely 
acknowledged that the imbalance between the intake and expenditure of energy results in obesity (Ahmad et al., 2020; 
Parray et al., 2018). 
Sedentary lifestyles and other environmental risk factors are considered major causes of obesity (Fig. 1) but they are not 
entirely responsible: genetic mutations can also lead to the condition (Choquet and Meyre, 2011). Mutations in genes such 
as Leptin (LEP), leptin receptor (LEPR), prohormone convertase 1 (PCSK1), melanocortin receptor (MC4R), 
proopiomelanocortin (POMC), single-minded homolog 1 (SIM), and brain-derived neurotrophic factor (BDNF) have been 
reported to be associated with obesity (Choquet and Meyre, 2011; Farooqi and O'rahilly,  2008). 
 
























Major causes of obesity and associated complications. 
There are a number of options for the treatment of obesity. These focus on changes in lifestyle, such as control of diet, 
physical exercise, weight-loss medications, and weight-loss surgeries (Chandrasekaran et al., 2012; Sun et al., 2016). 
Physiological interventions such as exercise and dieting are the preferred ways to reverse weight gain, but due to the 
modern lifestyle, these activities seem to be challenging to practice and maintain in the modern world.  This has therefore 
created a need for pharmacological interventions. Demand for anti-obesogenic drugs and weigh loss therapies has 
accelerated the development of these interventions within the global pharmaceutical industry (Sun et al., 2016). 
Pharmacological interventions can aid the management of weight loss by altering processes such as absorption of calories, 
altering appetite, preventing or altering the development of adipose tissue, and regulating the metabolism of the body. 
However, related adverse effects hinder their usage and limit their beneficial effects (Chandrasekaran et al., 2012). A 
significant example of this is Meridia (sibutramine), which acts as an appetite suppressant by inhibiting neurotransmitters 
within the brain and was withdrawn in 2010 from the US and Canadian markets due to adverse effects on the 
cardiovascular system, resulting in heart attacks and strokes. In the same year, Xenical (orlistat), another weight loss drug, 
underwent revised labeling due to reported adverse effects on the liver (Sun et al., 2016). Some other commercially 
available pharmacological drugs, including metformin, exenatide, rimonabant, and pramlintide have also been reported to 
cause abdominal pain, sleeplessness, restlessness, cardiovascular problems, and incontinence (Bond, 2006; DeFronzo et 
al., 2005; Herrmann et al., 2016; Hollander et al., 2003; Mukherjee et al., 2015; Pi-Sunyer et al., 2006; Sam et al., 2011; 
DPPR Diabetes Prevention Program Research Group, 2012; Siavash et al., 2017; Wang et al., 2017). Due to these adverse 
effects, natural products are now often preferred over pharmacological drugs, in the management of weight loss. 
Furthermore, many natural products have been consumed for this purpose for hundreds of years and are often considered 
as nontoxic and more effective than pharmacological drugs (Park et al., 2011). An ideal anti-obesity drug should be able 
to control weight gain, with little or no side effects (Rodgers et al., 2012) and pharmacological anti-obesogenic drugs 
should be prescribed only if their beneficial effects outweigh the adverse effects. As a result, there is a growing emphasis 
on the development of drugs from natural plant products due to their perceived effectiveness and minimal or absent side 
effects. In addition, plant-based products, either as standardized extracts or pure compounds, have historically provided 
innumerable opportunities for the discovery of drugs, due to their lack of adverse effects and wide chemical diversity 
(Sasidharan et al.,  2011). 
This review will comprehensively outline the anti-obesogenic mechanisms of action of plant products.  Their mechanisms 
of action include: inhibitory effects on the activity of lipases such as pancreatic lipase, increase in the expenditure of energy 
via processes such as brown adipogenesis, appetite suppression through control of leptin and ghrelin levels, enhancing the 
expression of lipolytic proteins such as hormone-sensitive lipase (HSL) and adipocytes triglycerides lipase (ATGL), and the 
inhibition of white adipose tissue (WAT) development. 
2 Inhibition of pancreatic lipase (PL) activity 
Lipids are essential to all living organisms: they are the building blocks of cellular membranes, can act as thermal isolators, 
and serve as a source of stored energy in the body. Nonetheless, excessive long-term intake of dietary lipids is one of the 
major causes in the development of obesity and is linked with other significant co-morbidities. Inhibition of dietary lipid 
digestion is an important approach in combating obesity, and a logical target for many anti-obesogenic pharmaceutical 
agents. Interference with the hydrolysis of lipids results in the reduction of the utilization of ingested lipids. Therefore, 
inhibition of lipases, responsible for the digestion and absorption of lipids, results in the decreased absorption of fats 
(Conforti et al., 2012). Consequently, one of the strategies for the screening and discovery of potential anti-obesogenic 
products is to investigate their inhibitory effects upon lipases. (Marrelli et al., 2013). A key example is pancreatic lipase (PL, 
also known as triacylglycerol acyl hydrolase), the principal enzyme of pancreatic juice, synthesized and secreted by the 
pancreas, and associated with absorption of dietary fats (Kim et al., 2016a,b). Dietary fats are usually consumed as a 
collection of triglycerides (TGs) that before absorption in the gastrointestinal tract, undergo a series of biochemical reactions 
(Lunagariya et al., 2014).  Ninety percent of dietary fat consists of TGs and they must be hydrolyzed prior to absorption. 
The products of TG hydrolysis are monoglycerides, and free fatty acids (FFAs); these form mixed micelles with cholesterol, 
lysophosphatidic acid, and bile salts. The micelles are then absorbed into enterocytes where TGs are resynthesized and 
then stored in mature adipocytes as an energy source (Birari and Bhutani, 2007). An excess of these TGs in adipocytes   is 
directly linked to obesity (Fig. 2). PL plays a crucial role in the hydrolysis of TGs and is responsible for the processing of 




PL inhibition is being widely studied to evaluate the potential of natural products to inhibit dietary fat absorption (Jamous 
et al., 2018; G.N. Kim et al., 2016; Marrelli et al., 2013). The blockbuster drug, orlistat, sold under the trade name Xenical, 
acts through the inhibition of pancreatic lipase and is used commercially as an anti-obesogenic drug. Orlistat is 
synthesized from the natural product lipstatin, a known lipase inhibitor (Lunagariya et al., 2014). Many plant extracts and 
their specific isolated bioactive compounds identified through their anti-obesogenic effects demonstrate inhibition of 
























Absorption of lipids in the body and physiological role of Pancreatic Lipase (PL). Plants products inhibit the activity of PL, thus preventing 
the hydrolysis of triglycerides (TGs) into monoglycerides (MGs) and free fatty acids (FFAs). Arrows indicate activation or further processing 
while bar indicates inhibition. 
Table 1 
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Jamous et al. (2018) screened 90 plant extracts for their inhibitory effects on the activity of crude porcine PL in vitro. 
Among those, the most active plants with the lowest IC50 values were Camellia sinensis (0.45 mg/mL), Ceratonia siliqua 
(leaves) (0.76 mg/mL), Curcuma longa (0.82 mg/mL), Sarcopoterium spinosum (1.2 mg/mL) and Mentha spicata (1.2 
mg/mL). Similarly, Ong et al. (2014) screened 32 medicinal plants found in Malaysia for their anti-porcine PL activity in 
vitro. Among those, the extracts of four plants (Eleusine indica, Myristica fragrans, Melastoma candidum and Phyla 
nodiflora) showed the highest inhibitory effects (31.3%, 20.3%, 19.720% and 18.2% inhibition of PL activity at 100 μg/mL 
respectively). Recently, Tiamyom et al. (2019) reported the porcine PL inhibitory effects of Gymnema inodorum extract. 
The extract inhibited the activity of PL in a dose-dependent manner with IC50 value of 982 μg/mL. Another study by 
Kim et al., (2016) reported the inhibitory effects of Diospyros kaki fruit, and Citrus unshiu peel mixture extract (PCM) on 
porcine PL activity in vitro. The same group also then evaluated the anti-obesogenic effects of this mixture in vivo in high 
fat-diet (HFD) mice.  The IC50 value against the PL activity levels found for PCM was 0.5 mg/mL. In addition, total 
cholesterol levels, serum triacylglycerol and visceral fat weight were significantly reduced when compared to the control 
HFD mice, which suggested that the administration of PCM might have reduced the absorption of fats by inhibiting the 
activity of PL. Similarly, Adnyana et al. (2014) showed porcine PL inhibitory effects of the ethanolic extracts of 
pomegranate leaves, it was observed that the extract inhibited the activity of PL in a dose-dependent manner. 
In addition to plant crude extracts, specific bioactive compounds from plants have also been shown to possess inhibitory 
effects on PL activity. Bustanji et al. (2011) documented the porcine PL inhibitory effects of trilactone terpenes, including 
ginkgolides and bilobalide. The results revealed that ginkgolides A & B and bilobalide inhibited the activity of PL with 
IC50 values of 22.9, 90.0, and 60.1 μg/mL, respectively. Apigenin has been shown to have activity against porcine PL, 
with inhibition rates exceeding 50% at a concentration of 0.8 mM (Guo et al., 2016). Similarly, 
quercetin, its monoglycoside and diglycoside forms, isoquercetin and rutin,  inhibited  the activity  of porcine PL (IC50)  at 
concentrations of 1.49, 0.97 and 1.1 mg/mL (Li et al., 2011). C-glycosidic flavones are also reported to  inhibit  porcine 
PL activity with IC50 values ranging from 18.5 ± 2.6 to 50.5 ± 3.9 μM (Lee et al., 2010). Glycosyl groups at 
positions 6 and 8 of the A ring showed maximum inhibitory effects on the activities of PL (Lee et al., 2010). Two other 
hydroxylated methoxy flavones, 3,7-dihydroxy-4′methoxyflavone and 3,7,3′-trihydroxy-4′-methoxyflavone have also 
been shown to inhibit the activity of porcine PL (Ahn et al., 2012). These two compounds inhibited the activity of PL    by 
21.8 and 24.8% respectively at a concentration of 100 μM. Dioscin, isolated from methanol extract of Dioscorea nipponica 
powder, also inhibited PL activity (IC50) at 20 μg/mL (Birari and Bhutani, 2007; Szewczyk and Sternbach, 2005). Ahn et 
al. (2012) showed the inhibitory effects of various bioactive compounds isolated from Broussonetia kanzinoki. Among 
those, broussonone A showed a non-competitive inhibitory effect on the activity of porcine PL with an IC50 value of 28.4 
μM. 
3 Increase in energy expenditure 
Adipose tissue in mammals has classically been characterized into two types based on morphology, functions, and 
anatomical locations: white adipose tissue (WAT), and brown adipose tissue (BAT) (Ahmad et al., 2020).  WAT and BAT, 
both originate from mesenchymal stem cells (MSCs) (Unser et al., 2015) through a well-orchestrated process known as 
adipogenesis (Fig. 3). Both of these tissues store energy in the form of lipids, whilst BAT contributes to dissipation of the 
stored energy in the form of heat (Velickovic et al., 2018). WAT is mainly responsible for the storage   of energy in the 
form of TGs. BAT supports control of core body temperature by a specialized process known as adaptive or non-shivering 
thermogenesis, in which chemical energy is transformed into heat (Azhar et al., 2016). Correspondingly, BAT protects 
against obesity due to its ability to dissipate calories as heat (Gill and La Merrill, 2017). BAT activity is inversely related to 
the occurrence of obesity (Ahmad et al., 2020). BAT releases heat from the available nutrients via a process that is 
uncoupled from the production of ATP by uncoupling protein 1 (UCP1) ( Kaisanlahti and Glumoff, 2018). UCP1 is the 
central activator of the thermogenic effect and induction of its expression by natural anti-obesogenic plant products is one 
route to reduceing obesity (Kajimura and Saito, 2014; Sun et al., 2016). The expression of UCP1 in WAT has also been 
reported in recent years (Dempersmier et al., 2015). Over-expression of UCP1 causes ‘browning’ of WAT, thus known as 
brite or beige adipose tissue. Browning is usually induced by hormonal stimulation and cold exposure. Brite or beige 
adipocytes are similar to BAT adipocytes in that they also generate heat by utilizing the available lipids in the body (Bi et 
al., 2014). Peroxisome proliferator-activated receptor γ 1 coactivator (PGC-1) regulates the expression of UCP1 during 
the development of brown fat or exposure to external stimuli such as cold or diet (Cooper et al., 2008; Gill and La Merrill, 
2017). PGC-1α is considered the founding member of the PGC-1 family. It increases mitochondrial biogenesis and is a 
critical regulator of BAT thermogenesis (Gill and La Merrill, 2017). Similarly, sirtuin 1 (SIRT1) is also known to play a 
key role in stimulating and activating brown adipogenesis, activating browning of WAT, and retarding the expansion of WAT 
(Sudhakar et al., 2018). Interest in the prevention of obesity by regulation of non-shivering thermogenesis in BAT and brite 
adipose tissue through phytochemicals has been rapidly increasing, due to their potential for minimal side effects. 
 
 
Various phytochemicals (Table 2 A and B) have previously been reported to activate browning of WAT and brown 
adipogenesis. For example, genistein upregulates the expression of PGC1-α and UCP1 (Aziz et al., 2017), hence 
promoting brown adipogenesis. Similarly, Formononetin, capsaicin, and myricetin have been shown to induce the 
browning of WAT by upregulating the genes, and transcriptional factors specifically expressed in BAT (Gautam et al., 2017; 
Hu et al., 2018). Capsaicin has been reported to activate the genes responsible for browning of WAT, including UCP1 and 
bone morphogenetic protein 8b (BMP8b) in WAT. Moreover, it also activates the energy sensor protein of the body, AMP-
activated protein kinase (AMPK), SIRT-1 and PGC-1 α (Baboota et al., 2014; Baskaran et al., 2016). AMPK is obligatory 
for the proper functioning of BAT (Day et al., 2017), and its activation correspondingly increases during brown 
adipogenesis (Bijland et al., 2013). Barbagallo et al. (2016) reported the anti-adipogenic and thermogenic effects of 
silibinin. Silibinin (a natural flavonoligan and the main active constituent of Silybum marianum, also known as milk thistle) 
at a concentration of 10 μM increased the gene expressions of UCPs (UCP1, 2 and 3), PGC-1α, PPAR-α and SIRT-1. 
Moreover, it also decreased the expression of key adipogenic genes, PPAR-γ, fatty acid-binding protein- 4 (FABP4) and 
fatty acid synthase (FAS). Likewise, phyllodulcin, a natural sweetener found in certain types of Hydrangea, also activates 
the browning of WAT by enhancing the expression of thermogenic genes in subcutaneous WAT (E. Kim et al., 2017). 
Cinnamaldehyde and thymol are also reported to act as browning agents. Cinnamaldehyde is one of the most abundant 
phytochemicals found in cinnamon and has been used for various medicinal purposes since medieval times (Azhar et al., 
2016). Cinnamaldehyde decreased the accumulation of visceral fat in a dose-dependent manner; in part by stimulating the 
interscapular BAT. It also increased the expression levels of UCP1 in high fat and high sucrose diet-fed mice (Azhar et 
al., 2016; Tamura et al., 2012). Thymol is a monoterpene phenolic compound and raises the expression of brown fat-
specific markers and protein levels, i.e. PGC-1α, hormone sensitive lipase (HSL), UCP1, and carnitine palmitoyl transferase 
1 (CPT1). Moreover, it also leads to increased phosphorylation of AMPK and acetyl-CoA carboxylase (ACC) (Choi et 
al., 2017). Arias et al. (2017) showed the synergistic effect of quercetin and resveratrol on WAT in rats. The combination 
of these two compounds significantly induced browning in the perirenal WAT of rats. Moreover, it also induced the protein 
expression of UCP1 in the interscapular BAT. Apigenin and naringenin have also been shown to cause elevated expression 
of UCP1 in BAT in a dose-dependent manner (Thaiss et al., 2016). Similarly, the prenylated flavonoid xanthohumol 
obtained from the hop plant (Humulus lupulus), activates the thermogenic program of adipose tissue (Azhar et al., 2016). 
Xanthohumol has been shown to increase the energy expenditure in various types of tissues including WAT and BAT, and 
its administration inhibits ATP synthase, increases the consumption level of oxygen and reactive oxygen species (ROS), 
leading to activation of AMPK and PGC-1α (Azhar et al., 2016; Kirkwood et al., 2013). Luteolin was shown to upregulate 
thermogenic genes and enhance energy expenditure in subcutaneous and brown adipose tissue (Zhang et al., 2019). It 
increased UCP1 expression and activated AMPK/PGC-1α signaling in C57BL/6 mice (Zhang et al., 2016). The inhibition 
of AMPK reversed the thermogenic effects of luteolin confirming its interaction with AMPK/PGC-1α signaling (Zhang et 
























Differentiation of white, brown, and beige adipocytes. Plant products (Extracts and specific phytochemicals) inhibit white adipogenesis 
and activate brown adipogenesis. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version 
of this article.) 
They upregulated the expression of genes and proteins involved in the regulation of brown adipogenesis such as UCP1, 
PGC-1α and PR-domain containing 16 (PRDM-16) in 3T3-L1adipocytes. PRDM-16 is an essential transcriptional factor 
involved in the differentiation of brown adipocytes (Park, 2014). Caffeine also induces brown adipogenesis (Clark et al., 
2019; Rebollo-hernanz et al., 2019; Velickovic et al., 2019), and hence increases thermogenesis. Exposure of mouse-
derived mesenchymal stem cells (MMSCs) to caffeine, induced the expression of UCP1 and enhanced cell metabolism 
and oxygen consumption. Additionally, caffeine also increased the expression of PGC-1α and mitochondrial biogenesis 
together with other BAT and beige specific gene markers (Velickovic et al., 2019). A polyphenolic compound, resveratrol 
has also been shown to induce the formation of brown-like adipocytes in WAT (Wang et al., 2015). It significantly increased 
the mRNA and protein expression of brown adipocyte marker genes such as UCP1 and PRDM-16 in vitro. Moreover, 
treatment with resveratrol also markedly increased the phosphorylation of AMPKα1 subunit. The browning-inducing 
effect of resveratrol was reversed in cells lacking AMPKα1 subunit, demonstrating that resveratrol induces brown-like 
adipocytes through activation of AMPK α1 (Wang et al., 2015). Other phytochemicals such as curcumin (Lone et al., 
2016), sudachitin (Tsutsumi et al., 2014), genicetin (Aziz et al., 2017), myricetin (Hu et al., 2018) and berberine (Zhang 
et al., 2014) also enhance brown adipogenesis. They either enhance the thermogenic activity of BAT by increasing the 
expression of BAT specific genes and transcriptional factors or enhance the browning of WAT by specifically expressing 

















Increased the expression of Tmem26, cited 1 and Tbx1. Upregulated the genes 
involved in the regulation of brown adipogenesis (UCP1and Prdm-16, PGC-1 α) 
 




Increased UCP1, PRDM-16, Cd137, Tbx1 genes, and UCP1, PGC-1 α and 
PRDM-16 protein expression. Enhanced the expression of lipolytic and FAs 
oxidation markers CPT1, PLIN, SIRT1 and ACSL1. 
 
 







Increased the expression of thermogenic genes, UCPs (UCP1, 2 and 3), PGC-1α, 
SIRT 1 and PPAR-α. 
 
 





Induced browning of 3T3-L1 primary white adipocytes. Increased protein level 
of p-ACC and HSL. Increased the expression of UCP1 and other browning 
inducing specific markers through activation of AMPK. 
 
 





Upregulated the expression of PGC1-α, UCP1, Sirt1. Increased the consumption 
level of oxygen 
 








Promoted thermogenesis, brown adipogenesis. Increased the expression of 
brown-selective genes UCP1, PRDM-16 and PGC-1 α. Increased mitochondrial 
biogenesis and oxygen consumption 
(Clark et al., 2019; 
Rebollo-hernanz et al., 
2019; 





Increased the expression of brown adipocytes-specific marker genes e.g UCP1, 
PGC-1α, PRDM-16, PPAR-α etc 
 
(Baboota et al., 2014) 








Thermogenic effects of phytochemicals (Cell Studies). 
alt-text: Table 2A 
 
Phytochemical                      Cell Type              Molecular Mechanism              Reference 
 


















Increased oxygen consumption, carbon dioxide production and 
respiratory exchange ratio. Increased thermogenesis by enhancing the 
expression UCP1 through activation of AMPK/PGC-1 α signaling 
 
 






Activated the brown adipogenic markers i-e UCP1, AMPK, SIRT, 
PRDM-16 and PGC-1α 
 







Diminished visceral fat deposition. Activated interscapular BAT 
and increased the expression of UCP1 
 








Inhibited ATP synthase, increased the oxygen consumption levels. 
Activated AMPK and PGC-1α 
 
(Azhar et al., 2016; 









Significantly increased the expression of fat-browning related 
genes, UCP1, PRDM-16 and PGC-1α in scWAT. Decreased the 
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Increased O2 consumption, energy expenditure and UCP1 expression 
in sWAT 
 






Increased the body's temperature and consumption of oxygen. 
Enhanced the browning of iWAT by enhancing the expression of 
PGC-1α and UCP1. Moreover, it also enhanced mitochondrial 












Increased UCP1 and thermogenic genes expressions in BAT, WAT 
and primary adipocytes 
 
 





Significantly increased the protein and mRNA expression of brown 
adipogenic markers-UCP1, PGC-1α, PRDM-16 etc. Also induced 
beige adipogenesis by increasing fatty acid oxidation, multilocular 




Wang et al. (2015) 
4 Appetite suppressors 
 
High-calorie intake is the root cause of obesity. Various kinds of dietary supplements, marketed as appetite suppressors are 
already targeting a desperate overweight and obese population (Yimam et al., 2019). The search for natural and safe 
appetite-suppressing agents has sparked special interest in industry and the general population throughout the world (van 
Heerden, 2008). The regulation of body weight and control of appetite is a multifactorial problem. Various hormonal and 
neurological signals regulate the state of satiety in human bodies (Yun, 2010). Neural signal peptides, for instance, 
dopamine, histamine and serotonin and their associated receptors are correlated with the state of satiety, and these may be 
the targets of specific phytochemicals/plants crude extracts in the treatment of obesity (Yun, 2010). Plant products that give 
a perceived enhancement of satiety through an increase in adrenaline level and activation of the sympathetic nervous system 
are considered beneficial for controlling weight gain (Belza et al., 2007; Morton et al., 2014). Hormones associated with 
adiposity are thought to be the main communicators of body energy status to the central nervous system (Chandrasekaran 
et al., 2012). Two prominent and well-known hormones associated with hunger and food intake are leptin and ghrelin 
(Klok et al., 2007). They regulate food intake, hunger, energy homeostasis, and promote satiety by interacting with the 
hypothalamus in the brain (Singh, 2014) and are known to have a major impact on the balance of energy. Leptin mediates 
long term regulation of energy balance whereas ghrelin is known to be a fast-acting hormone, and it seems to play a role in 
meal initiation (Klok et al., 2007). 
4.1 Leptin 
 
Leptin is mainly produced by mature adipocytes in white adipose tissue, but its effects extend across the body, targeting for 
example the heart, kidneys, and sympathetic nervous system (González-Castejón and Rodriguez-Casado, 2011). Leptin is 
a peptide hormone that mediates its effects through leptin receptors (LEPR) located primarily in the hypothalamus of brain. 
Activation of these receptors can regulate food intake, promote satiety and energy homeostasis by initiating different 
signaling cascades (Ford et al., 2013; Klok et al., 2007; Singh, 2014; Van  Der  Klaauw  and Farooqi, 2015). Primarily, 
leptin acts as an energy sensor and causes reduction of appetite via signaling through the hypothalamus (Mukherjee et al., 
2015), but in obesogenic conditions, leptin signaling is impaired, resulting in an excessive drive to eat, a condition known 
as hyperphagia (Van Der Klaauw and Farooqi, 2015). Overexpression of leptin genes and the resultant increased levels of 
leptin in the blood are known to cause leptin-resistance as the hypothalamus of the brain becomes less sensitive due to over 
activation of receptors. Synthesis and secretion of leptin   are dependent on various factors such as growth hormone, insulin, 
steroid hormone and glucose levels (Szkudelska et al., 2009). Targeting these factors, or leptin synthesis and secretion 
directly with plant products is a potential approach to combat obesity. 
In the past, different plant products had been tested for their appetite suppressive effects and the treatment of obesity (Table 
3). Resveratrol decreased the secretion of leptin in rat adipocytes, and orally administered resveratrol significantly reduced 
the blood leptin concentration in mice exhibiting hyperleptinemia (Baur et al., 2006). In another study, resveratrol directly 
decreased the level of leptin secretion in isolated rat adipocytes, when treated with insulin and glucose (Szkudelska et al., 
2009). Similarly, administration of 2800 mg/day of hydroxy citric acid (HCA), an extract from G. Cambogia, resulted in a 
reduction in food intake, serum leptin level, and baseline body weight in humans (Preuss et al., 2004; Tucci, 2010). And 
in the same vein, purified anthocyanins (cyanidin-3-rutinoside, cyanidin-3- glucoside and pelargonidin-3-glucoside) from 
Morus australis Poir significantly decreased the leptin secretion levels, alongside other factors such as adipocyte size, lipid 
accumulation and weight gain in HFD C57BL/6 mice (Azzini et al., 2017; Wu et al., 2013a). Catechin is also thought to 
have inhibitory effects on the excess secretion of leptin. It has been shown in clinical trials that the administration of catechin 
ranging from 270 to 1200 mg/day resulted in reduced body weight and lowering of serum leptin levels (Rains et al., 2011; 
Sun et al., 2016). Epigallocatechin 3 Gallate (EGCG) and capsaicin are also known to have appetite suppressing effects 
and increase the sensation of fullness, and decrease the desire to eat (Janssens et al., 2014; Fernandes et al., 2018). 
Table 3 
List of selected phytochemicals with known appetite suppressing effects. 
Phytochemical Structure 
Animal Model 
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In addition to the aforementioned bioactive compounds, plant extracts (Prunus mume and Lithospermum erythrorhizon) 
synergistically prevent the impairment of energy, glucose, and lipid regulation, through potentiating hypothalamic leptin 
and insulin signaling in rats (Ko et al., 2013). Likewise, Wu et al. (2013b) reported the effects of blueberry and mulberry 
juice on the secretion of leptin in high fat-diet (HFD) obese mice. The juice significantly reduced serum leptin levels when 
compared to control HFD mice. 
4.2 Ghrelin 
 
Ghrelin is a 28 amino acid peptide acetylated on serine 3, which is synthesized in the stomach but it has also been identified 
in other tissues such as the pancreas, gastrointestinal tract, adrenal cortex and ovary (Klok et al., 2007).  It binds to and 
activates the growth hormone secretagogue receptor (GHS-R), leading to stimulation of food uptake, fat deposition and 
growth hormone release (Pradhan et al., 2013; Singh, 2014). The hypothalamus modifies the energy status of the body by 
sensing peripheral ghrelin levels (Singh, 2014). Lowering the secretion of ghrelin is therefore another strategy for fighting 
weight gain. Numerous plant products have been shown to inhibit the abnormal secretion    of ghrelin. Celestino et al. 
(2017) showed that a combination of South American herbal extracts reduced food intake through gastrointestinal hormone 
modulation in obese and overweight women. They showed that these combined extracts decreased acylated ghrelin levels, 
an active isoform of ghrelin, after mealtimes, indicating the appetite suppressing effects of these extracts. Similarly, Sengupta 
et al. (2012) reported that Dolichos biflorus and Piper betle extracts (herbal formulation LI10903F) significantly reduced 
serum ghrelin levels in 50 human subjects after eight weeks of supplementation. Extracts of Phaseolus vulgaris have also 
been shown to control appetite in human subjects when given as supplements with mixed meals to 12 volunteers. Three 
hours after meal consumption, the extracts of P. vulgaris suppressed secretion of ghrelin and effected the sensation of satiety, 
inducing a lower desire to eat (Spadafranca et al., 2013). A compound known as P57, isolated from a South African 
succulent of the Hoodia family has been shown to act as a prominent appetite suppressor in preclinical trials (Gooda Sahib 
et al., 2012). It has been used in preclinical studies and shown to have a good safety profile and significantly promoted 
weight loss in dogs, mice and rats (Habeck, 2002). Similarly, other extracts and herbal supplements such as Citrus 
aurantium, ephedra and hydroxy citric acid also exhibit appetite suppressing properties (Rezaie et al., 2015). Based on 
these studies, it can be concluded that plant products show promise for use as appetite regulating agents in obesogenic 
conditions. 
5 Regulation of lipid metabolism 
A key step in the metabolism of lipids from stored fat is lipolysis (Luglio et al., 2015).  Control of lipolysis has significant 
potential for the development of anti-obesogenic products (Sun et al., 2016). Lipolysis is the breakdown of 
TGs to form monoglycerides and free fatty acids, which can be used by other tissues. Adipose tissue is the only tissue that 
has the ability to hydrolyze stored TGs and mobilize fatty acids into the bloodstream (Chaves et al., 2011). Lipolysis is a 
key step in the absorption and accumulation of fats in mature adipocytes. Initially, it was thought that the most important 
enzyme in the process of lipolysis is HSL, but, with the advancement of knowledge, it was revealed that two other 
enzymes, ATGL and monoacylglycerol lipase (MAGL) are also involved in the breakdown of lipids to free fatty acids 
(Luglio et al., 2015). Therefore, complete hydrolysis of TGs into fatty acids in adipose tissue is dependent on the activities 
of ATGL, HSL, and MAGL (O'Neill et al., 2013). HSL is mostly found in both brown and white adipose tissue (Luglio et 
al., 2015). HSL and ATGL are known to be the main lipases in WAT, and the mobilization of fatty acids by WAT is 
dependent on the activity of these two lipases. Together they are also considered to be responsible for 95% of the total 
hydrolysis of TGs in adipocytes (Chaves et al., 2011; Schweiger et al., 2006). ATGL is primarily responsible for the 
hydrolysis of TGs, while HSL is known to preferentially hydrolyze diglycerides (DGs), with a tenfold higher effect than 
on TGs (Chaves et al., 2011). AMPK is also known to be involved in lipid metabolism (lipolysis), and increased activity 
levels can be achieved by administering plant products such as berberine and resveratrol (O'Neill et al., 2013).  Similarly, 
β-adrenergic receptor activation is also known to cause lipolysis in white adipocytes (Bordicchia et al., 2014), illustrating 
that altering the expression of key regulatory enzymes involved in lipolysis can prove advantageous in the fight against 
obesity. 
 
There are a number of reports evidencing the lipolytic effects of plant products or specific phytochemicals (Table 4). 
Gómez-Zorita et al. (2013) showed the lipolytic effect of resveratrol. Resveratrol significantly stimulated the expression 
of HSL but not ATGL in genetically obese rats. In another study, Lasa et al. (2012) reported the lipolytic effects of 
resveratrol through ATGL management. Resveratrol enhanced the gene and protein level of ATGL in adipose tissue, and 
it was concluded that lipolytic effects regulated by resveratrol in human and murine adipocytes are through mainly 
changes in ATGL levels. 18β-Glycyrrhetinic acid and Ginkgolide C are also reported to enhance lipolysis. 18β- 
Glycyrrhetinic enhances lipolysis, and enhances the mRNA level of HSL and ATGL (Moon et al., 2012). Ginkgolide     
C increases the production of lipolytic proteins (ATGL and HSL) and activates AMPK (Liou et al., 2015).  Similarly, the 
flavonoid quercetin has also been shown to induce lipolysis. In OP9 cells, which were induced to differentiate into mature 
adipocytes, quercetin dose-dependently induced lipolysis in these cells by enhancing the expression of both HSL (>2-
fold) and ATGL (>4-fold) (Seo et al., 2015). Jiang et al. (2016) showed the lipolytic effects of berberine in 3T3-L1 
adipocytes. Berberine extracted from Coptis chinensis increased the expression of ATGL and phosphorylated HSL (p-
HSL) in a time-dependent manner, and reduced TG level by 10% in 3T3-L1 adipocytes. Moreover, it was also revealed 
that AMPK was involved in the enhanced expression of p-HSL and ATGL after treatment with berberine in 3T3-L1 
adipocytes. Likewise, ursolic acid (a pentacyclic triterpenoid) stimulated lipolysis in primary-cultured rat adipocytes (Li et 
al., 2010). It was shown that ursolic acid increased lipolysis by translocating the HSL to the lipid droplet from the cytosol 
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Table 4 
Lipolytic effects of phytochemicals (Cell and Animal Studies). 
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Apart from specific phytochemicals, crude plant extracts also exhibit lipolytic effects. Black soybean (Glycine max (L.) 
Merr.) is rich in anthocyanins. Its ethanolic extract was shown to enhance the activity of AMPK, HSL, and lipoprotein 
lipase (LPL) in mesenteric fat of C57BL/6N mice (S.Y. Kim et al., 2015). Extract of Vigna angularis (Black adzuki bean) 
also showed anti-obesogenic and lipolytic effects. The extract significantly decreased the accumulation of TGs in a dose-
dependent manner and enhanced the expression of prominent lipolytic genes for HSL to 457%, at 1 mg/mL concentration. 
Similarly, the mRNA expression of ATGL was enhanced to 303% at 1 mg/mL and 427% at 2 mg/mL (M. Kim et al., 2015). 
Chen et al. (2014) reported the anti-obesogenic and lipolytic effects of methanolic extract of black garlic. The extract 
significantly enhanced lipolysis and increased the expression of ATGL and HSL along with other anti-adipogenic genes. 
Based on these reports, it is clear that plant products either in the form of crude extracts or specific phytochemicals have 
latent lipolysis regulating effects. Further investigation is needed for these compounds to be used as anti-obesogenic agents 
after successful clinical trials. 
6 Adipocyte differentiation 
Adipose tissue controls energy balance and the homeostasis of lipids. Excessive calorie intake and low energy expenditure 
can result in hypertrophy and hyperplasia of adipocytes (Tang and Lane, 2012), two of the primary detrimental conditions, 
which relate to adipose tissue. Hyperplasia is the recruitment of mesenchymal stem cells (MSCs) to the adipogenic lineage, 
resulting in an increase in the number of adipocytes in WAT (Tang and Lane, 2012). Similarly, hypertrophy refers to the 
expansion in the size of mature WAT adipocytes due to increased calorie intake and lipid accumulation. Mature WAT 
adipocytes store TGs and release them when necessary, in response to energy demands. Blocking of the principal factors 
that influence the development of new adipocytes, by natural products may prove effective in the development of anti-
obesity therapies (Sun et al., 2016; Xiao et al., 2010). The development of WAT from pre-adipocytes is a well-defined 
process, known as white adipogenesis, which is regulated by a cascade of positive and negative regulators (Ahmad et al., 
2020). PPAR- γ is a critical pro-adipogenic transcription factor that positively regulates the differentiation of preadipocytes 
to mature adipocytes (Sarjeant and Stephens, 2012). Positive regulators of adipogenesis have been shown to induce the 
activation of PPAR-γ mRNA. Members of CCCAAT/enhancer binding protein family (C/EBPs), some of the kruppel like 
factors (KLFs)  (Sarjeant  and  Stephens, 2012) and early beta-cell factors 1 and 2 (EBF 1 and 2) (Jimenez et al., 2007) are  
inducers of PPAR-γ  mRNA, hence promote adipocyte differentiation. Repressors of adipogenesis include  members  of 
the  KLFs family  such as KLF 2, 3, 7, 16 (Jang et al., 2016,b; Jiang et al., 2015; Pollak et al., 2018; Sue et al., 2008), 
GATA-binding factors 2 and 3 (GATA 2,3) (Tong et al., 2000), Wnt /β- catenin signaling (T. Chen et al., 2018), and the 
Hh signaling pathway (Fontaine et al., 2008; Moseti et al., 2016). 
It has been shown that plant products can inhibit the differentiation of preadipocytes into mature white  adipocytes through 
up- or downregulation of these negative and positive adipogenic factors (Table 5 A and B). For example, 6- gingerol, 
found in ginger, inhibits adipogenic differentiation through activation of the Wnt/β-catenin signaling pathway  (Li and Zhou, 
2015). This compound was shown to lower the mRNA levels of key adipogenic and lipogenic factors in 3T3-L1 cells such 
as mRNA levels of C/EBP-α, PPAR-γ, and protein expression of FAS and ACC through the activation of Wnt/β-catenin 
signaling pathway. Similarly, toosendanin, a triterpenoid, has also been shown recently to inhibit adipogenesis through the 
Wnt/β-catenin dependent pathway (Chen et al., 2018,b). Toosendanin significantly reduces the expression of central 
adipogenic factors C/EBP-α and PPAR-γ, FAS, and ACC through activation of the Wnt/β-catenin dependent pathway in 
3T3-L1 cells and in vivo in male C57 BL/C6 mice (T. Chen et al., 2018). Loganic acid (oral administration with 10 and 
50 mg/kg/day) significantly inhibits total fat increase, fatty hepatocyte deposition in the liver, body weight gain, and 
adipocyte enlargement in the abdominal visceral fat tissues in ovariectomized mice and also inhibits the expression of 
positive regulators of adipogenesis in 3T3-L1 cells (Park et al., 2018). In another study, the administration of 
isobavachalcone isolated from the Japanese Angelica keiskei plant resulted in decreased adipocyte proliferation by 38.6% 
at day 2 (D2) and 31.0% at day 8 (D8). It also reduced intracellular lipid contents by 75% and decreased the protein levels 
of PPAR-γ and C/EBP-α. Levels of sterol regulatory element-binding protein -1c (SREBP-1c), ACC1, and FAS mRNA 
in 3T3-L1 pre-adipocytes were also lowered (Lee et al., 2018). Caffeic acid and hydroxytyrosol have also been reported 
to have anti-adipogenic properties and suppress the protein expression levels of PPAR-γ (Lutfi et al., 2017). Recently an 
anthocyanin, Delphinidin-3-O-β- glucoside (D3G) has also been shown to inhibit the differentiation of pre-adipocytes, 
reduce lipid accumulation, and downregulate key lipogenic and adipogenic markers, SREBP-1, PPAR-γ, C/EBP-α and 
FAS in 3T3-L1 adipocytes ( Park et al., 2019). Kumkarnjana et al. (2018) reported the anti-adipogenic effects of four 
flavonoids (kaempferide, pectolinarigenin, dillenetin and 4,2′-dihydroxy-4′,5′,6′-trimethoxychalcone) extracted from the 
leaves of Chromolaena odorata. These flavonoids dose-dependently inhibited the accumulation of lipids in differentiating 
3T3-L1 adipocytes of which 2′-dihydroxy-4′,5′,6′-trimethoxychalcone was the most potent one. It inhibited cellular lipid 
accumulation by 75%–90% in a dose-dependent manner. Similarly two other flavonoids (flavones), 5,7-dimethoxyflavone 
(Song et al., 2016) and 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone (Wang et al., 2016) have also been shown to attenuate 
white adipogenesis in 3T3-L1 cells and HFD-induced obese mice. Pterostilbene has also been shown to have anti-
adipogenic effects (Seo et al., 2017). It reduces the accumulation of lipids and suppresses the expression of positive central 
regulators of adipogenesis i-e PPAR-γ, C/EBP-α, adipocyte protein 2 (aP2) and C/EBP-β (Seo et al., 2017). Tangeretin, 
nobiletin and hesperetin also show the same effect. They reduce triglyceride levels and downregulate the expression level 
of PPAR-γ in differentiating 3T3-L1 adipocytes (J. Chen et al., 2018). Similarly, anthocyanins from Vitis coignetiae 
enhance AMPK activation, decrease the number of lipid droplets, reduce TG level and inhibit the expression of PPAR-
γ, C/EBP-α,- β and REBP-1c in 3T3-L1 adipocytes (Han et al., 2018). Oxyresveratrol and cyanomaclurin also show the 
same effect: they reduce TG contents in differentiating 3T3-L1 cells (Tan et al., 2015). Moreover, they also inhibits cell 
proliferation, induce cell cycle arrest, and down-regulate the expression of PPAR-γ and C/EBP-α (Tan et al., 2015). 
Kaempferol-3-O-rutinoside from Solidago virgaurea also inhibits the differentiation of pre-adipocytes through 
suppression of PPAR-γ and C/EBP-α expression (Y.S. Jang et al., 2016). Tricin, a hydroxylated methoxyflavone, inhibits 
the lipid accumulation in 3T3-L1 adipocytes by 37% at 6 μg/mL and significantly decreases the mRNA level of PPAR-γ, 
CEBPs/and SREBP-1  
 at 1.5 μg/mL concentration (Lee et al., 2015). Recently purpurin has also been reported to reduce blood glucose, 
cholesterol, and triglycerides levels in Male C57BL/6 mice and inhibit differentiation of 3T3-L1 adipocytes apparently    by 











Anti-Adipogenic effects of bioactive compounds from plants (Cell Studies). 
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Loganic Acid Ovariectomized 
mice 
Oral administration (10 and 50 mg/kg/day) of loganic acid 
inhibited total fat increase, body weight gain, adipocyte 
enlargement in the abdominal visceral fat tissues and fatty 
hepatocyte deposition in the liver 
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Oral administration of purpurin (40 mg/kg and 80 mg/kg) reduced 
weight gain by 34 and 55%. Moreover, the increased blood 
glucose, cholesterol, and triglycerides levels caused by HFD, were 
reduced by purpurin treatments (40 and 80 mg/kg) by 24 and 
78%, 27 and 76%, and 64 and 123%. 
 
 
Nam et al. 
(2019) 
 
Again, besides the specific bioactive compounds of plants, crude extracts can also have anti-adipogenic effects. Combined 
extracts of green coffee, cinnamon, and ginger significantly decrease the level of low-density lipoprotein (LDL), TGs, and 
total lipids in obese Sprague-Dawley rats (Raoof et al., 2017). Gyeongshingangjeehwan 18 (GGEx18), a herbal 
composition from Rheum palmatum L, Laminaria japonica Aresch and Ephedra sinica reduces lipid accumulation in 3T3-
L1 adipocytes by 41%, 54% and 70% at 0.1, 1 and 10 μg/mL concentrations respectively. It also decreases visceral adipose 
tissue weight by 46% and 24% at 250 and 500 mg/kg doses in HFD C57BL/6J mice (Oh et al., 2015). Similarly, Curcuma 
longa L extracts also showed anti-adipogenic effects in Sprague Dawely rats (J.H. Kim et al., 2016). The extract suppressed 
adipocyte differentiation and lipogenesis, decreased mRNA expression of FAS, ACC, aP-2 and lipoprotein lipase (LPL) 
(J. H. Kim et al., 2016). Camellia sinensis extract reduces the expression of pro-inflammatory cytokines interleukin-6 (IL-
6), tumor necrosis factor α (TNF- α) genes, serum leptin level and inhibits the absorption of fatty acids, resulting in reduce 
body weight and fat accumulation in HFD rats (Xu et al., 2015). Extracts of Tropaeolum majus have also been shown to 
reduce triglyceride level up to 25.8%–54.7%, decrease PPAR-γ expression level by 23.0%–90.4% and C/EBP-α by 45.8% 
and 71.9% at different concentrations in 3T3-L1 cells (G.C. Kim et al., 2017). 
7 Summary and outlook 
Obesity is a common disorder caused by the interaction of behavioural, environmental, genetic and nutritional factors, and 
its prevalence is accelerating worldwide. Excessive consumption of calorific foods, and increasingly sedentary lifestyles 
are the predominant causative factors for this rise in obesity. Returning to healthy lifestyles, for example, daily exercise and 
reducing excessive calorific intake is the surest route to successful weight loss, but for many, it is extremely challenging to 
maintain. For decades, synthetic chemicals have been developed as anti-obesogenic drugs. Despite generating positive 
results, they have also caused adverse effects that muted their benefits. Traditionally used medicinal plants, which contain a 
wide range of natural chemicals, have been used for the treatment of many infectious as well as chronic disorders including 
obesity. These natural products from plants may play a supportive role in combating obesity by helping obese people to 
lose weight. There is also potential for synergistic activity, conferred by the combination of multiple natural products to 
increase their anti-obesogenic activities and mode of action on multiple targets, which may prove to be advantageous over 
other chemical treatments. Previously published results regarding anti-obesogenic compounds, are either based on in vitro 
(cell) studies or mouse models and therefore do not guarantee the same results in humans. Additional preclinical 
development followed by appropriate clinical trials must therefore be performed to evaluate the effectiveness of bioactive 
compounds to understand their safety, bioavailability, pharmacokinetics and efficacy. Clinical trials should be planned 
carefully to evaluate both immediate and long-term side effects of these bioactive compounds. An investigation into 
promising targets and identification of unique regulators of both WAT and BAT development are still needed for formulating 
appropriate natural products as drugs against obesity. In conclusion, natural products derived from medicinal plants, have 
the potential if developed appropriately, to deliver anti-obesogenic drugs that could play a central role in the management 
of obesity. 
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the anti-obesogenic mechanisms of action of plant  products’’. Graphical abstract 
Plant products tackle obesity through various mechanisms of action. These include inhibition of pancreatic lipase activities, increase 
in energy expenditure, appetite regulation, lipolysis, and inhibition of  white adipose tissue development. 
Highlights 
Obesity results due to imbalance between intake and expenditure of energy 
In obesogenic conditions the excessive fats are accumulated in white adipocytes 
Brown and Beige adipose tissues utilize the stored fats to generate heat through non-shivering   thermogenesis 
Plant products promote brown adipogenesis and inhibit white adipogenesis 
Plant products prevent the excessive accumulation of fats in white adipocytes through various molecular mechanisms 
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